165 related articles for article (PubMed ID: 38444990)
1. Incidence and inhospital outcomes of coronavirus disease 2019-associated pulmonary aspergillosis in the United States.
Sharma A; Sharma A; Soubani AO
Ann Thorac Med; 2024; 19(1):87-95. PubMed ID: 38444990
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for COVID-19-associated pulmonary aspergillosis: a systematic review and meta-analysis.
Gioia F; Walti LN; Orchanian-Cheff A; Husain S
Lancet Respir Med; 2024 Mar; 12(3):207-216. PubMed ID: 38185135
[TBL] [Abstract][Full Text] [Related]
3. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis.
Chong WH; Saha BK; Neu KP
Infection; 2022 Feb; 50(1):43-56. PubMed ID: 34570355
[TBL] [Abstract][Full Text] [Related]
4. Influenza-Associated Aspergillosis: Nationwide Trends, Predictors and Outcomes From 2005 to 2014.
Sharma A; Mishra T; Kumar N; Soubani AO
Chest; 2020 Nov; 158(5):1857-1866. PubMed ID: 32565269
[TBL] [Abstract][Full Text] [Related]
5. Covid-19-associated pulmonary aspergillosis in mechanically ventilated patients: incidence and outcome in a French multicenter observational cohort (APICOVID).
Desmedt L; Raymond M; Le Thuaut A; Asfar P; Darreau C; Reizine F; Colin G; Auchabie J; Lorber J; La Combe B; Kergoat P; Hourmant B; Delbove A; Frérou A; Morin J; Ergreteau PY; Seguin P; Martin M; Reignier J; Lascarrou JB; Canet E
Ann Intensive Care; 2024 Jan; 14(1):17. PubMed ID: 38285382
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Pulmonary Aspergillosis in Critically Ill Patients: A Nationwide, Multicenter, Retrospective Cohort Study.
Kim SH; Hong JY; Bae S; Lee H; Wi YM; Ko JH; Kim B; Joo EJ; Seok H; Shi HJ; Yoo JR; Hyun M; Kim HA; Jang S; Mun SJ; Kim J; Kim MC; Jung DS; Kim SH; Peck KR
J Korean Med Sci; 2022 May; 37(18):e134. PubMed ID: 35535369
[TBL] [Abstract][Full Text] [Related]
7. COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study.
Iqbal A; Ramzan M; Akhtar A; Ahtesham A; Aslam S; Khalid J
Cureus; 2021 Aug; 13(8):e16982. PubMed ID: 34527462
[TBL] [Abstract][Full Text] [Related]
8. Coronavirus Disease 2019-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients.
Permpalung N; Chiang TP; Massie AB; Zhang SX; Avery RK; Nematollahi S; Ostrander D; Segev DL; Marr KA
Clin Infect Dis; 2022 Jan; 74(1):83-91. PubMed ID: 33693551
[TBL] [Abstract][Full Text] [Related]
9. COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study.
Hurt W; Youngs J; Ball J; Edgeworth J; Hopkins P; Jenkins DR; Leaver S; Mazzella A; Molloy SF; Schelenz S; Wise MP; White PL; Yusuff H; Wyncoll D; Bicanic T
Thorax; 2023 Dec; 79(1):75-82. PubMed ID: 37657925
[TBL] [Abstract][Full Text] [Related]
10. COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding.
Huang JR; Shen HC; Sun CY; Chen WC; Chen YM; Feng JY; Yang KY
J Formos Med Assoc; 2022 Dec; 121(12):2617-2625. PubMed ID: 35953342
[TBL] [Abstract][Full Text] [Related]
11. Incidence, diagnosis and outcomes of COVID-19-associated pulmonary aspergillosis (CAPA): a systematic review.
Chong WH; Neu KP
J Hosp Infect; 2021 Jul; 113():115-129. PubMed ID: 33891985
[TBL] [Abstract][Full Text] [Related]
12. Risk of Coronavirus Disease 2019-Associated Pulmonary Aspergillosis Based on Corticosteroid Duration in Intensive Care Patients.
Shah M; Reveles K; Moote R; Hand E; Kellogg Iii D; Attridge RL; Maselli DJ; Gutierrez GC
Open Forum Infect Dis; 2023 Mar; 10(3):ofad062. PubMed ID: 36879627
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit With Coronavirus Disease 2019: A Multicenter Retrospective Study.
Xu J; Yang X; Lv Z; Zhou T; Liu H; Zou X; Cao F; Zhang L; Liu B; Chen W; Yu Y; Shu H; Yuan S; Hu M; Huang C; Shang Y
Front Med (Lausanne); 2021; 8():753659. PubMed ID: 34869450
[No Abstract] [Full Text] [Related]
14. Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
Gangneux JP; Dannaoui E; Fekkar A; Luyt CE; Botterel F; De Prost N; Tadié JM; Reizine F; Houzé S; Timsit JF; Iriart X; Riu-Poulenc B; Sendid B; Nseir S; Persat F; Wallet F; Le Pape P; Canet E; Novara A; Manai M; Cateau E; Thille AW; Brun S; Cohen Y; Alanio A; Mégarbane B; Cornet M; Terzi N; Lamhaut L; Sabourin E; Desoubeaux G; Ehrmann S; Hennequin C; Voiriot G; Nevez G; Aubron C; Letscher-Bru V; Meziani F; Blaize M; Mayaux J; Monsel A; Boquel F; Robert-Gangneux F; Le Tulzo Y; Seguin P; Guegan H; Autier B; Lesouhaitier M; Pelletier R; Belaz S; Bonnal C; Berry A; Leroy J; François N; Richard JC; Paulus S; Argaud L; Dupont D; Menotti J; Morio F; Soulié M; Schwebel C; Garnaud C; Guitard J; Le Gal S; Quinio D; Morcet J; Laviolle B; Zahar JR; Bougnoux ME
Lancet Respir Med; 2022 Feb; 10(2):180-190. PubMed ID: 34843666
[TBL] [Abstract][Full Text] [Related]
15. Comparison of risk factors and outcome of patients with and without COVID-19-associated pulmonary aspergillosis from Pakistan: A case-control study.
Nasir N; Farooqi J; Zubair SM; Ayub M; Khan S; Wiqar MH; Mahmood SF; Jabeen K
Mycoses; 2023 Jan; 66(1):69-74. PubMed ID: 36111367
[TBL] [Abstract][Full Text] [Related]
16. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
Prattes J; Wauters J; Giacobbe DR; Salmanton-García J; Maertens J; Bourgeois M; Reynders M; Rutsaert L; Van Regenmortel N; Lormans P; Feys S; Reisinger AC; Cornely OA; Lahmer T; Valerio M; Delhaes L; Jabeen K; Steinmann J; Chamula M; Bassetti M; Hatzl S; Rautemaa-Richardson R; Koehler P; Lagrou K; Hoenigl M;
Clin Microbiol Infect; 2022 Apr; 28(4):580-587. PubMed ID: 34454093
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-Associated Pulmonary Aspergillosis (CAPA).
Dimopoulos G; Almyroudi MP; Myrianthefs P; Rello J
J Intensive Med; 2021 Oct; 1(2):71-80. PubMed ID: 36785564
[TBL] [Abstract][Full Text] [Related]
18. COVID-19-associated invasive pulmonary aspergillosis in a tertiary care center in Mexico City.
Vélez Pintado M; Camiro-Zúñiga A; Aguilar Soto M; Cuenca D; Mercado M; Crabtree-Ramirez B;
Med Mycol; 2021 Jul; 59(8):828-833. PubMed ID: 33724423
[TBL] [Abstract][Full Text] [Related]
19. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
Feys S; Gonçalves SM; Khan M; Choi S; Boeckx B; Chatelain D; Cunha C; Debaveye Y; Hermans G; Hertoghs M; Humblet-Baron S; Jacobs C; Lagrou K; Marcelis L; Maizel J; Meersseman P; Nyga R; Seldeslachts L; Starick MR; Thevissen K; Vandenbriele C; Vanderbeke L; Vande Velde G; Van Regenmortel N; Vanstapel A; Vanmassenhove S; Wilmer A; Van De Veerdonk FL; De Hertogh G; Mombaerts P; Lambrechts D; Carvalho A; Van Weyenbergh J; Wauters J
Lancet Respir Med; 2022 Dec; 10(12):1147-1159. PubMed ID: 36029799
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Risk Factors of COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit-A Monocentric Retrospective Observational Study.
Gregoire E; Pirotte BF; Moerman F; Altdorfer A; Gaspard L; Firre E; Moonen M; Fraipont V; Ernst M; Darcis G
Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
